PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643635
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1643635
The global electrophysiology market generated approximately $9.5 billion in revenue in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 13.3%, reaching $26.1 billion by 2032. This growth is driven by technological advancements, an increasing need for ablation and diagnostic catheters, and a rising number of cardiac ablation procedures.
Key Insights
Ablation catheters held the largest market share in 2024 and are expected to continue growing due to their minimally invasive nature and effectiveness in treating cardiac arrhythmias. The development of advanced technologies, such as radiofrequency and cryoablation, further boosts their adoption.
North America led the market in 2024, driven by a high prevalence of cardiac arrhythmias, increasing approvals for electrophysiology devices, and the presence of key industry players. The Asia-Pacific region is anticipated to experience the highest growth, fueled by a growing geriatric population, rising healthcare expenditures, and advancements in electrophysiology technologies.
The COVID-19 pandemic impacted healthcare delivery worldwide, leading to the postponement or reduction of elective electrophysiological procedures. Despite these challenges, electrophysiologists played a crucial role in managing COVID-19-related cardiovascular complications and providing urgent care.